Basic Materials / Specialty ChemicalsBSE
$26.66
+0.06 (+0.23%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-79.9M · quality 49.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.3B
P/E
19.2x
↑EV/EBITDA
11.7x
↑ROE
14.9%
↑Gross Margin
20.2%
↓Debt/Equity
2.11
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+35.2%
FCF CAGR
—
FCF margin
-14.2%
FCF / Net income
-2.99x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.43B · net income $67.8M · FCF $-202.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.43B | $1.43B | $975.1M | $714.5M | $577.4M |
| Net Income | $67.8M | $67.8M | $39.8M | $-8.7M | $-16.9M |
| EBITDA | $194.1M | $194.1M | $121.0M | $51.4M | $35.6M |
| EPS | 1.39 | 1.39 | 0.98 | -0.21 | -0.41 |
| Gross Margin | 20.2% | 20.2% | 15.8% | 18.8% | 17.7% |
| Operating Margin | 8.8% | 8.8% | -2.1% | -0.2% | -2.9% |
| Net Margin | 4.8% | 4.8% | 4.1% | -1.2% | -2.9% |
| Balance Sheet | |||||
| Debt/Equity | 2.11 | 2.11 | 5.32 | 18.81 | 14.78 |
| Current Ratio | 2.00 | 2.00 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-202.6M | $-202.6M | $-69.8M | $-79.9M | $-43.1M |
| Returns | |||||
| ROE | 14.9% | 14.9% | 22.0% | -16.8% | -28.0% |
| Valuation | |||||
| P/E | 19.18 | 19.18 | 28.06 | — | — |
| EV/EBITDA | 11.66 | 11.66 | 17.11 | 36.73 | 40.66 |
| P/B | 2.85 | 2.85 | 6.19 | 17.80 | 9.25 |
| Growth & Yield | |||||
| Revenue Growth | 46.3% | 46.3% | 36.5% | 23.7% | — |
| EPS Growth | 41.8% | 41.8% | 566.7% | 48.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.4%
EPS terminal req.
$2.37
Spread vs growth
22.4%
5Y implied EPS CAGR
15.5%
EPS terminal req.
$2.86
Spread vs growth
26.3%
10Y implied EPS CAGR
12.7%
EPS terminal req.
$4.61
Spread vs growth
29.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-13.2%
Start / end P/E
31.3x → 19.2x
EPS bridge
0.98 → 1.39
Residual
-16.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.